Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group
International Journal of Hematology（2020）
Key words
Chronic myeloid leukemia, Tyrosine kinase inhibitor, Dasatinib, Treatment-free remission
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined